Effect of hypothalamic-hypophysary inhibitory factor on mesangial cell activation

Hypertension. 1995 Dec;26(6 Pt 1):905-11. doi: 10.1161/01.hyp.26.6.905.

Abstract

We examined the effect of a sodium pump inhibitor isolated from bovine hypothalamus and pituitary tissues on contraction, proliferation, and calcium mobilization in primary cultures of rat mesangial cells. Hypothalamic-hypophysary inhibitory factor (HHIF) inhibited rubidium uptake in a concentration-dependent manner (0.2 U/mL: 56.8 +/- 6.3% inhibition). It also induced a concentration- and time-dependent decrease in planar cell surface area. Maximal contraction (25 +/- 5% reduction in cell size) was reached at 60 minutes with a concentration of 0.2 U/mL. This effect was inhibited by both verapamil and TMB-8 (10(-5) mol/L). HHIF was also observed to increase DNA synthesis (0.2 U/mL: 4361 +/- 168 versus 2129 +/- 162 cpm per well under control conditions) and cell proliferation (0.2 U/mL: 52,290 +/- 1931 versus 10,512 +/- 121 cells per well under control conditions). Both effects were also inhibited by verapamil and TMB-8. Moreover, HHIF induced the expression of immediate early genes c-fos and c-jun mRNA. HHIF-induced effects were accompanied by an increase in cytosolic free calcium (203 +/- 58 versus 101 +/- 2 nmol/L under control conditions), which was inhibited by verapamil and TMB-8. In summary, HHIF induces mesangial cell contraction and proliferation; these effects seem to be mediated by an increase in cytosolic free calcium levels.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Base Sequence
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Cattle
  • Cell Division
  • Cells, Cultured
  • Cytosol / metabolism
  • DNA / biosynthesis
  • Electrophoresis, Agar Gel
  • Enzyme Inhibitors / pharmacology*
  • Gallic Acid / analogs & derivatives
  • Gallic Acid / pharmacology
  • Gene Expression
  • Genes, fos
  • Genes, jun
  • Glomerular Mesangium / cytology*
  • Glomerular Mesangium / drug effects
  • Glomerular Mesangium / metabolism*
  • Molecular Sequence Data
  • Ouabain / antagonists & inhibitors
  • Ouabain / pharmacology*
  • Polymerase Chain Reaction
  • RNA, Messenger / genetics
  • Rats
  • Rats, Wistar
  • Surface Properties
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Enzyme Inhibitors
  • RNA, Messenger
  • sodium-potassium ATPase inhibitory factor
  • 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
  • Ouabain
  • Gallic Acid
  • DNA
  • Verapamil
  • Calcium